These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 23381582)
1. Prognostic significance of Fbw7 in human melanoma and its role in cell migration. Cheng Y; Chen G; Martinka M; Ho V; Li G J Invest Dermatol; 2013 Jul; 133(7):1794-802. PubMed ID: 23381582 [TBL] [Abstract][Full Text] [Related]
2. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway. Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4. Tang Y; Cheng Y; Martinka M; Ong CJ; Li G Carcinogenesis; 2014 Jan; 35(1):86-95. PubMed ID: 24130172 [TBL] [Abstract][Full Text] [Related]
4. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158 [TBL] [Abstract][Full Text] [Related]
5. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer. Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of cytoplasmic p27 expression in human melanoma. Chen G; Cheng Y; Zhang Z; Martinka M; Li G Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232 [TBL] [Abstract][Full Text] [Related]
7. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion. Jin X; Yang C; Fan P; Xiao J; Zhang W; Zhan S; Liu T; Wang D; Wu H J Biol Chem; 2017 Apr; 292(15):6269-6280. PubMed ID: 28242758 [TBL] [Abstract][Full Text] [Related]
8. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor. Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938 [TBL] [Abstract][Full Text] [Related]
9. Role of the ubiquitin ligase Fbw7 in cancer progression. Cheng Y; Li G Cancer Metastasis Rev; 2012 Jun; 31(1-2):75-87. PubMed ID: 22124735 [TBL] [Abstract][Full Text] [Related]
10. Role of ING4 in human melanoma cell migration, invasion and patient survival. Li J; Martinka M; Li G Carcinogenesis; 2008 Jul; 29(7):1373-9. PubMed ID: 18375955 [TBL] [Abstract][Full Text] [Related]
11. [Effects of UO-126 on proliferation and fbw7 expression of HeLa cells]. Sun D; Shen Y; Wang SH; Xiang ZW; Xie YS; Jiang X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):138-40. PubMed ID: 20230673 [TBL] [Abstract][Full Text] [Related]
13. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma. Guo H; Cheng Y; Martinka M; McElwee K Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521 [TBL] [Abstract][Full Text] [Related]
14. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation. Wang R; Wang Y; Liu N; Ren C; Jiang C; Zhang K; Yu S; Chen Y; Tang H; Deng Q; Fu C; Wang Y; Li R; Liu M; Pan W; Wang P Cell Res; 2013 Jun; 23(6):803-19. PubMed ID: 23507969 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional repression of c-Jun's E3 ubiquitin ligases contributes to c-Jun induction by UV. Anzi S; Finkin S; Shaulian E Cell Signal; 2008 May; 20(5):862-71. PubMed ID: 18295447 [TBL] [Abstract][Full Text] [Related]
16. Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase. Mo JS; Ann EJ; Yoon JH; Jung J; Choi YH; Kim HY; Ahn JS; Kim SM; Kim MY; Hong JA; Seo MS; Lang F; Choi EJ; Park HS J Cell Sci; 2011 Jan; 124(Pt 1):100-12. PubMed ID: 21147854 [TBL] [Abstract][Full Text] [Related]
17. FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation. Tong J; Tan S; Zou F; Yu J; Zhang L Oncogene; 2017 Feb; 36(6):787-796. PubMed ID: 27399335 [TBL] [Abstract][Full Text] [Related]
18. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Zhao D; Zheng HQ; Zhou Z; Chen C Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041 [TBL] [Abstract][Full Text] [Related]
19. PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity. Schülein C; Eilers M; Popov N FEBS Lett; 2011 Jul; 585(14):2151-7. PubMed ID: 21620836 [TBL] [Abstract][Full Text] [Related]
20. The two faces of FBW7 in cancer drug resistance. Wang Z; Fukushima H; Gao D; Inuzuka H; Wan L; Lau AW; Liu P; Wei W Bioessays; 2011 Nov; 33(11):851-9. PubMed ID: 22006825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]